Last updated: 17 June 2019 at 2:54am EST

Eugene R Corasanti Net Worth




The estimated Net Worth of Eugene R Corasanti is at least $7.03 Milione dollars as of 23 July 2014. Eugene Corasanti owns over 3,000 units of Conmed stock worth over $6,242,833 and over the last 21 years Eugene sold CNMD stock worth over $791,100.

Eugene Corasanti CNMD stock SEC Form 4 insiders trading

Eugene has made over 18 trades of the Conmed stock since 2011, according to the Form 4 filled with the SEC. Most recently Eugene exercised 3,000 units of CNMD stock worth $220,110 on 23 July 2014.

The largest trade Eugene's ever made was exercising 112,500 units of Conmed stock on 13 March 2012 worth over $2,912,625. On average, Eugene trades about 4,456 units every 15 days since 2003. As of 23 July 2014 Eugene still owns at least 85,087 units of Conmed stock.

You can see the complete history of Eugene Corasanti stock trades at the bottom of the page.



What's Eugene Corasanti's mailing address?

Eugene's mailing address filed with the SEC is 525 FRENCH RD, , LITICA, NY, 13502.

Insiders trading at Conmed

Over the last 21 years, insiders at Conmed have traded over $105,028,573 worth of Conmed stock and bought 56,468 units worth $2,754,510 . The most active insiders traders include Jerome J. Lande, Joseph J Corasanti e Dirk Kuyper. On average, Conmed executives and independent directors trade stock every 8 days with the average trade being worth of $759,159. The most recent stock trade was executed by Charles Farkas on 5 September 2024, trading 1,000 units of CNMD stock currently worth $39,640.



What does Conmed do?

conmed corporation is a global medical technology company that specializes in the development and sale of surgical and patient monitoring products and services that allow our physician customers to deliver high quality care and as a result, enhanced clinical outcomes for their patients. our products are technological leaders in the specialties that we serve: orthopaedics, general surgery, gynecology, gastroenterology, pulmonology, and anesthesiology. conmed's mission, and the focus of every employee around the world, is to improve the quality of health care by designing, producing and marketing innovative, high-quality products. our emphasis is on our customer’s satisfaction and on our enhanced patient outcomes. we strive to demonstrate thoughtful leadership, provide meaningful opportunities for employees, and be a responsible member of the local communities in which we conduct business. conmed is headquartered in beautiful, upstate new york (utica), and employs approximately 3500



Complete history of Eugene Corasanti stock trades at Conmed

Persona
Trans.
Transazione
Prezzo totale
Eugene R Corasanti
Chairman of the Board e CEO
Opzione $116,220
23 Jul 2014
Eugene R Corasanti
Chairman of the Board e CEO
Opzione $323,280
1 Jun 2014
Eugene R Corasanti
Chairman of the Board e CEO
Opzione $314,000
20 Nov 2013
Eugene R Corasanti
Chairman of the Board e CEO
Opzione $110,250
7 Jun 2013
Eugene R Corasanti
Chairman of the Board e CEO
Opzione $243,682
1 Jun 2013
Eugene R Corasanti
Chairman of the Board e CEO
Opzione $185,925
2 May 2013
Eugene R Corasanti
Chairman of the Board e CEO
Opzione $543,251
4 Jan 2013
Eugene R Corasanti
Chairman of the Board e CEO
Opzione $1,332,172
2 Jan 2013
Eugene R Corasanti
Chairman of the Board e CEO
Opzione $1,827
12 Dec 2012
Eugene R Corasanti
Chairman of the Board e CEO
Opzione $474,594
10 Sep 2012
Eugene R Corasanti
Chairman of the Board e CEO
Opzione $776,906
6 Sep 2012
Eugene R Corasanti
Chairman of the Board e CEO
Opzione $62,616
1 Jun 2012
Eugene R Corasanti
Chairman of the Board e CEO
Opzione $5,448
17 May 2012
Eugene R Corasanti
Chairman of the Board e CEO
Opzione $2,912,625
13 Mar 2012
Eugene R Corasanti
Chairman of the Board e CEO
Opzione $1,245,625
28 Oct 2011
Eugene R Corasanti
Chairman of the Board e CEO
Opzione $38,682
1 Jun 2011
Eugene R Corasanti
Chairman of the Board e CEO
Opzione $143,988
16 May 2011
Eugene R Corasanti
Chairman of the Board e CEO
Vendita $791,100
2 Mar 2011


Conmed executives and stock owners

Conmed executives and other stock owners filed with the SEC include: